Search Results - Tujague, R.

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Measurements of Pressure Waves Generated by Pulsed Electric Discharges in Water

    Measurements of Pressure Waves Generated by Pulsed Electric Discharges in Water by Bacqueyrisses, Y., Reess, T., De Ferron, A., Novac, B. M., Tujague, R., Morell, A.

    Request full text
    Conference Proceeding
    Save to List
    Saved in:
  2. 2
    Full dose, daily sofosbuvir treatment in end-stage renal disease: tolerability & safety of largest ESRD patient cohort exposed to this drug

    Full dose, daily sofosbuvir treatment in end-stage renal disease: tolerability & safety of largest ESRD patient cohort exposed to this drug by Nazario, H.E, Modi, A.A, Ndungu, M, Ramirez, R, Tujague, L, Weinstein, J.S

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Excellent cure rates in largest ESRD patient cohort who completed treatment with full dose, daily sofosbuvir-based regimens

    Excellent cure rates in largest ESRD patient cohort who completed treatment with full dose, daily sofosbuvir-based regimens by Nazario, H.E, Modi, A.A, Ndungu, M, Ramirez, R, Tujague, L, Weinstein, J.S

    Published in Journal of hepatology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Sofosbuvir-Based, Ribavirin-Free Regimens in Patients with Chronic Hepatitis C and End-Stage Renal Disease: A Look at Safety, Tolerability and Efficacy

    Sofosbuvir-Based, Ribavirin-Free Regimens in Patients with Chronic Hepatitis C and End-Stage Renal Disease: A Look at Safety, Tolerability and Efficacy by Nazario, H.E, Modi, A, Ndungu, M, Ramirez, R, Tujague, L, Weinstein, J

    Published in Journal of hepatology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    FRI-220 - Excellent cure rates in largest ESRD patient cohort who completed treatment with full dose, daily sofosbuvir-based regimens

    FRI-220 - Excellent cure rates in largest ESRD patient cohort who completed treatment with full dose, daily sofosbuvir-based regimens by Nazario, H.E., Modi, A.A., Ndungu, M., Ramirez, R., Tujague, L., Weinstein, J.S.

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    FRI-219 - Full dose, daily sofosbuvir treatment in end-stage renal disease: tolerability & safety of largest ESRD patient cohort exposed to this drug

    FRI-219 - Full dose, daily sofosbuvir treatment in end-stage renal disease: tolerability & safety of largest ESRD patient cohort exposed to this drug by Nazario, H.E., Modi, A.A., Ndungu, M., Ramirez, R., Tujague, L., Weinstein, J.S.

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    SAT-164 - Sofosbuvir-Based, Ribavirin-Free Regimens in Patients with Chronic Hepatitis C and End-Stage Renal Disease: A Look at Safety, Tolerability and Efficacy

    SAT-164 - Sofosbuvir-Based, Ribavirin-Free Regimens in Patients with Chronic Hepatitis C and End-Stage Renal Disease: A Look at Safety, Tolerability and Efficacy by Nazario, H.E., Modi, A., Ndungu, M., Ramirez, R., Tujague, L., Weinstein, J.

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    TACC3 expression is tightly regulated during early differentiation

    TACC3 expression is tightly regulated during early differentiation by Sadek, C.M., Pelto-Huikko, M., Tujague, M., Steffensen, K.R., Wennerholm, M., Gustafsson, J.-Å.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    O34

    O34 by Tujague, Jennifer, MPH, Woodward-Lopez, Gail, MPH, RD, Godbole, Suneeta, BS, Bui, Nancy, BS, Lim, Stephanie, Crawford, Pat, DrPh

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: